Managing IP testimonials – Ted Chwu, Bird & Bird and Catherine Zheng, Deacons

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Managing IP testimonials – Ted Chwu, Bird & Bird and Catherine Zheng, Deacons

Here are some more comments from our readers about Managing IP

Ted Chwu

Ted Chwu, Partner, Bird & Bird:

“Time and again Managing IP has proven itself to be a go-to resource for any professional engaged in intellectual property law. The reputation that Managing IP journalists have built up over the years means that they have access to the most important and innovative thinkers in the industry, and consequently the breadth of insight that their articles present is amongst the best in the business.”

Catherine Zheng

Catherine Zheng, Partner, Deacons:

“Managing IP magazine has always proved to be an insightful and timely resource. The feature articles tackle topical issues and really get to the heart of the issue at hand. I also appreciate the professional approach whenever I have any interactions with the magazine or staff.”




You too can enjoy a subscription to Managing IP and until Friday you will save up to 30% when you register your interest in this offer.

more from across site and SHARED ros bottom lb

More from across our site

Julia Bishop is director of IP at Twilio in the US
Hellberg is an IP director at Essity in Sweden
Palińska is the business & IP law lead at CD Projekt Red in Poland
Teemu Itälä is head of legal and compliance for technology standards at Nokia in Finland
Schwitulla is the head of litigation management at Nokia in Germany
David Degen is senior IP counsel at Novartis, Switzerland
Demetrio Roberto Cavicchia is an IP director at Angelini Pharma in Italy
Almeida is the IP group leader at Bosch in Brazil
Amanda Luz is brand protection manager - global at Adidas in the US
Samantak Ghosh is vice president of IP at Avere Therapeutics in the US
Gift this article